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Volatile carboxylic acid profiling in physiological 
fluids: direct injection into a gas 
chromatograph/mass spectrometer * 
We present a procedure for the profiling of the volatile carboxylic acids and 
neutral compounds in blood or urine using the direct injection of the acidified 
sample into a gas chromatograph interfaced with a mass spectrometer by a jet 
separator. The non-volatile components remain at the head of the SP-1000 column 
while the volatile components move through the column. Up to sixty physiological 
samples can be analyzed before any degradation in mass spectrometer operating 
parameters is observed. 
Some inborn errors of metabolism are characterized by an increase in the plasma 
and/or urine concentration of carboxylic acids. Metabolic disorders such as pro- 
pionic acidemia [l], methylmalonic aciduria [2,3], maple syrup urine disease [4], 
isovaleric acidemia [4] and glutaric acidemia type II (5,651 show increased concentra- 
tions of volatile carboxylic acids in blood and/or urine. Gas chromatography/mass 
spectrometry (GC/MS) represents the current method of choice for the profiling of 
volatile carboxylic acids [7,8]. This method requires the isolation of carboxylic acids 
from physiological fluids by vacuum distillation [6], extraction [9.10], silicic acid 
absorption [ll] or ion exchange chromatography 1121 and conversion to the oxime- 
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TMS. TMS or methyl eater derivative prior IO inJection Irlto tt~c g;i, 
chromatograph/mass spectrometer [7.X1. Isolation and derivatir.ation of carhoxvlic 
acids may result in significant losses of the more volatile compounds. and mat result 
in compound dec~~nlpositi~n because of the itlst~biiit~ of the derivatized carhoaylic 
acid 17.81. In addition, derivatization may afford multiple prctducts [7.x]. The 
isolation and derivatization processes preclude the detection and identification of 
volatile neutral compounds which may bc of clinical significance [ 11 .I 31. 
We have recently developed a rapid procedure for the gas chromatographic 
profiling of volatile carboxylic acids and neutral compounds in plasma and urine 
[14] which used direct injection of the acidified sample into a gas ~hr~~mat~~graph 
with flame ionization detection. We now report the adaptation of this technique to 
GC/MS employing direct injection of acidified physiological fluids into a gas 
chromatograph interfaced to a mass spectrometer by a jet separator. The mass 
spectrometer facilitates peak identification and quantification by total ion ahun- 
dance (TIA) and/or selected ion monitoring (SIM). 
Materials and methods 
Materiuls 
All carboxylic acid standards were purchased either from Sigma Chemical Co. 
(St. Louis, MO, USA) or from Aldrich Chemical Company (Milwaukee, WI, USA) 
and were used as received. 
Equipment 
A Hewlett Packard 5995B GC/MS (Palo Alto. CA, USA) equipped with a 10% 
SP-1000/l% H,PO, on lOO/ZOO Chromosorb WAW (1.83 m X 2 mm i.d.) glass GC 
column (Supefco, Inc., Bellefonte, PA, USA) was used for all deter~nations. 
The SP-1000 column was conditioned at 19O*C with a helium flow rate of 20 
mI/min. Periodic injection of a 1% formic acid solution was repeated until a stable 
baseline resulted (1-2 days). 
Urine To 1.00 ml of urine was added 10 ~1 of a 1.02 mg/ml trimethylacetic acid 
[ll] (internal standard) solution and the pH of the sample was adjusted to 1.0 by the 
addition of 1 mol/l HCI. A I-PI aliquot was injected on to the SP-1000 column. GC 
conditions: column, 150°C isothermal; injector, 230°C; flow rate, 20 ml He/min. 
Mass spectrometer: transfer line, 28O’C; ion source, 200°C: mass analyzer. 230°C. 
The usual analysis time was 45-55 min. 
Plasma To 1 .OO ml of 1 mmol/l HCl was added 10 ~1 of a 1.02 mg/ml 
trimethylacetic acid solution (internal standard). A 10-1-11 aliquot was mixed with 10 
~1 of plasma and a l-p1 aliquot was injected on to the SP-1000 column. The GC/MS 
parameters were the same as those used for urine sampies. 
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The method of standard additions was used to quantify volatile carboxylic acids. 
Peak height ratio (anafyte peak h~~ght/inte~a~ standard peak height) was de- 
termined from the total ion abundance chromatogram or from the selected ion 
chromatogram, thus permitting either to be used for quantification. In the selected 
ion mode, the mass (m/r) of the base peak in the mass spectrum of each acid was 
the ion used for quantification. 
The day-to-day and run-to-Ron peak height variation was determined without an 
internal standard using both total ion abundance and setected ion monitoring. The 
GC/MS parameters were kept constant during these determinations. 
Results and discussion 
Figure 1 shows the total ion abundance chromatogram of a standard solution that 
is used to determine when a new SP-1000 column is fully conditioned and to 
monitor column performance. Peaks were identified by their relative retention time 
(trimethylacetic acid internal standard) and their mass spectrum. 2-Methylbutanoic 
acid and 3-methylbutanoic acid coelute but they can be differentiated by their mass 
spectra and thus by selected ion monito~ng. A &Lafferty rearrangement [15] yields 
an m/z 60 base peak in the mass spectrum of 3-methy~but~oi~ acid while the same 
rearrangement yields an m/z 74 base peak for 2-methylbutanoic acid. 
A comprehensive listing of all volatile carboxylic acids detected and identified in 
plasma or urine samples is presented in Table I. The relative retention time, 
approximate total ion abundance detection threshold (peak height is twice the noise) 
and the major fragments observed in the mass spectrum are included for each 
compound. Because of the injection port temperature (23O*C), it was anticipated 
that hydroxycarboxylic acids would undergo an acid catalyzed thermal dehydration 
to the corresponding unsaturated carboxylic acid [16,17]. However, dehydration did 
not occur and the hydroxyc~boxyl~c acids were detected unchanged. 
The total ion abundance chromatogram of a normal urine and plasma sample is 
shown in Fig. 2. Formic acid is a syringe contaminate (see ‘Materials and Methods’) 
Fig. 1. Total ion abundance chromatogram of a standard volatile carboxylic acid mixture. 1, Formic acid; 
2, propanoic acid; 3, isobutyric acid; 4, butanoic acid; 5, 2 + 3-methylbutanoic acid; 6, pentanoic acid: 7, 
crotonic acid: X, ~-methylcrotollic acid: 9, hexanoic acid. 
and is found in every chromatogram. Lactic acid is a normal plasma ~~~mpotlent ;~nd 
has been detected in every plasma profile. Volatile neutral i,nd phcnolic cc~mpc~und~ 
are observed (Fig. 3) in many of the profiles (normal and abnormal) of phylological 
fluids [ 131. The volatile neutral and phenolic compounds in physiological fluids ma? 
he of dietary or drug origin. 
However, Zlatkis et al [13] reported a direct relationship between urinary ;md/ot 
serum volatile alcohol and carbonyl compound concentrations and diabetes mellitw. 
TABLE I 
Volatile carhoxylic acids in plasma and urine 
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a Total ion abundance under normal profile conditions 
h Not determined. 
-- .____.___ 
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75(hn\e). 73. 57. 45 
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72(hasc.55. 45 
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74(hase). 73.6X. 57 
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100, 55(base). 4.5 
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respirator viral infection and renal insufficiency. Burke et al 1181 have profiled the 
urinary vofatile compounds from ~henylketonur~a, maple syrup urine disease and 
isovaleric acidemia patients. They are able to differentiate these diseases by the 
major volatile compounds founds in the urinary profile. The relationship between 
the concentration of volatile neutral and phenolic compounds in ~h~s~ologi~al fluids 
and metabolic abnormalities needs further investigation. The volatile neutral and 
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Fig. 2A. Total ion abundance chromatngram of a normal urine sample. Peak 1 is the internal standard. 6. 
Total ion abundance chromatogram of a normal plasma sample. 1. formic acid; 2, internal standard; 3, 
lactic acid. 
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Fig. 3. Total ion abundance chromatogram of an abnormal urine sample. 1, Acetic acid; 2. formic acid; 3, 
internal standard; 4. tiglic acid; 5, 3-ket~2-methylpenta~oic acid; 5, p-cresol: 7, lactic acid. 
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phenolic compounds we have identified in profiles of physiological fluids ;irc listed 
in Table II. 
The total ion abundance chromatogram of an abnormal urine sample is shown in 
Fig. 3. Lactic acid. tiglic acid (2-methyl-2-buteneoic acid) and 3-keto-2-methylpenta- 
noic acid are not detectable in a normal urine profile. The presence of 3-keto-2- 
methylpentanoic acid in this urine was postulated to be due to valproic acid therapy. 
Neither the 3-keto-2-methylpentanoic acid peak nor the tiglic acid peak was present 
in a urine sample obtained 72 h after removal of the patient from valproic acid. 
However, the lactic acid peak remained. Tiglic acid may have been produced from 
the metabolism of 3-keto-2-methylpentanoic acid. 
The total ion abundance chromatograms of urine samples from a child with 
vitamin B,,-responsive methylmalonic aciduria are shown in Fig. 4. The 230°C 
injection port of the gas chromatograph quantitatively decarboxylates methyl- 
malonic acid to propanoic acid [19,20]. Upon admission to the hospital (Fig. 4A) the 
child’s urinary methylmalonic acid excretion was 6.7 mg/mg creatinine (35.0 
~mol/ml). After 48-h of vitamin B,, therapy, (Fig. 4B) the urinary methylmalonic 
acid excretion was 1.0 mg/mg creatinine (5.1 ~mol/ml). Normal urinary methyl- 
malonic acid excretion for a child of the same age ib 30.6 + 14.2 pg/mg creatinine 
[71. 
The volatile carboxylic acids in physiological fluids can be quantified directly 
from the total ion abundance chromatogram or by the selected ion monitoring of a 
second injection of the sample. Because of the specificity of the technique. selected 
ion monitoring affords the best results (Table III). The base peak in the mass 
spectrum of each carboxylic acid was the ion monitored. Peak height ratio de- 
termination (analyte peak height/internal standard peak height) using the method of 
standard addition was used to obtain the least squares correlation coefficients shown 
in Table III. 
The day-to-day and the run-to-run peak height variation of a standard volatile 
carboxylic acid mixture was determined for both total ion abundance and selected 
ion monitoring (Table IV). The magnitude of the variability for each procedure 
shows the need of an internal standard for quantification. 
TABLE II 
Volatile neutral and phenolic compounds found in physiological fluids 
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Fig. 4A. Total ion abundance chromatogram of a urine sample from a child having vitamin B,z responsive 
methylmalonic aciduria. Sample taken upon admission to the hospital. Peak 1. propanoic acid from 
methylmalonic acid (see text). 35.0 ymol/ml; peak 2, internal standard. B. Total ion abundance 
chromatogram of a urine sample from the same child after 48 h of vitamin B,, therapy. Peak 1. propanoic 
acid from methylmalonic acid, 5.1 nmol/ml; peak 2, internal standard. 
The metabolic abnormalities that can be detected by volatile carboxylic acid 
profiling are characterized by urine and plasma volatile carboxylic acid concentra- 
tions that are at least ten times the normal value. The detection limits of this 
technique (Table I) in urine dictates that any volatile carboxylic acid present in the 
total ion abundance chromatogram must be present in a greater than normal 
concentration. With the exception of lactic acid, the same is true for plasma. A small 
lactic acid peak (lactic acid peak height/internal standard peak height I 1) is 
TABLE III 
Volatile carboxylic acid quantification: least squares correlation 
Name RRT TIA a SIM’ 
Propanoic 0.81 




3-Methylbutanoic (isovaleric) 1.46 
Pentanoic 1.89 
2-Butanoic 2.06 
2-Ketopropanoic (pyruvic) 2.13 
2-Methyl-2-butanoic 2.82 
2-Ketopentanoic 4.10 























2-Hydroxypropanoic (lactic) 9.26 0.98 
3-Hydroxybutanoic 11.77 0.91 
’ Manual peak height determination. 
b Peaks coelute, thus the compound cannot be quantified by TIA profiling. 




’ Manual peak height determination. 
observed in all plasma total ion abundance profiles. Those metabolic abnormalities 
that are not characterized by elevated plasma or urine volatile carboxylic acid 
concentrations cannot be detected by this technique. These disorders must be 
detected by the GC or CC/MS profiling of TMS derivatized carboxylic acids. 
Contamination of the mass spectrometer by physiological fluids has not been the 
problem we anticipated. We believe the non-volatile components of plasma and 
urine are held on the injector side of the SP-1000 column and thus never enter the jet 
separator or the mass spectrometer. We routinely change columns and clean the jet 
separator after 40-50 physiological samples have been profiled. The mass spec- 
trometer ‘down time’ has not been excessive. In addition, ghost peaks have not been 
a problem. We routinely inject several microliters of a 1% formic acid solution on to 
the column after each profile. This reduces ghost peak formation and cleans the jet 
separator. 
The rapid profiling technique described in this report provides for a markedly 
shortened interval between the time a sample is received and when the diagnostic 
information is available to the physician. In most inborn errors of carboxylic acid 
metabolism, a rapid and accurate diagnosis is essential if life-saving measures are to 
be effective. Precise identification of the defects permits the administration of 
cofactor therapy or the reduction of toxic dietary nutrients. The sooner these 
measures are initiated, the better the chance of a good outcome for the patient. 
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